Christopher R. Stone

Array ( [id] => 8095837 [patent_doc_number] => 20120083529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'USE OF JASMONATE ESTER DERIVATIVES FOR TREATING BENIGN HYPERPROLIFERATIVE SKIN DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/376917 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10267 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083529.pdf [firstpage_image] =>[orig_patent_app_number] => 13376917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630377 [patent_doc_number] => 20100311714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => '1H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/792187 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89682 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311714.pdf [firstpage_image] =>[orig_patent_app_number] => 12792187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128387 [patent_doc_number] => 20120088744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/375288 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17381 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088744.pdf [firstpage_image] =>[orig_patent_app_number] => 13375288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039413 [patent_doc_number] => 20110092462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'USE OF HIGH-DOSE OXAZAPHOSPHORINE DRUGS FOR TREATING IMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/777729 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11736 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092462.pdf [firstpage_image] =>[orig_patent_app_number] => 12777729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253203 [patent_doc_number] => 20120157518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Sublingual Spray Formulation Comprising Dihydroartemesinin' [patent_app_type] => utility [patent_app_number] => 13/265518 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7836 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157518.pdf [firstpage_image] =>[orig_patent_app_number] => 13265518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6508640 [patent_doc_number] => 20100210645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Certain Chemical Entities, Compositions and Methods' [patent_app_type] => utility [patent_app_number] => 12/765820 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25512 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210645.pdf [firstpage_image] =>[orig_patent_app_number] => 12765820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5977691 [patent_doc_number] => 20110071082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'LONG LASTING ANTI-ANGIOGENIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/759153 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20408 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20110071082.pdf [firstpage_image] =>[orig_patent_app_number] => 12759153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576125 [patent_doc_number] => 20100273777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Compounds for Modulating TRPV3 Function' [patent_app_type] => utility [patent_app_number] => 12/755118 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 52154 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273777.pdf [firstpage_image] =>[orig_patent_app_number] => 12755118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253098 [patent_doc_number] => 20120157422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'MARKER' [patent_app_type] => utility [patent_app_number] => 13/263159 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3500 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157422.pdf [firstpage_image] =>[orig_patent_app_number] => 13263159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063423 [patent_doc_number] => 20110245311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Histidine Derivatives' [patent_app_type] => utility [patent_app_number] => 12/918995 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9732 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245311.pdf [firstpage_image] =>[orig_patent_app_number] => 12918995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535379 [patent_doc_number] => 08049005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Substituted tetrahydropyrazolo-pyrido-azepine compounds' [patent_app_type] => utility [patent_app_number] => 12/751383 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37731 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/049/08049005.pdf [firstpage_image] =>[orig_patent_app_number] => 12751383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7683688 [patent_doc_number] => 20100240723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE' [patent_app_type] => utility [patent_app_number] => 12/751193 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8217 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240723.pdf [firstpage_image] =>[orig_patent_app_number] => 12751193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6350401 [patent_doc_number] => 20100249120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'SUBSTITUTED PYRAZOLO-PYRROLO-PYRIDINE-DIONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/751396 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46556 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249120.pdf [firstpage_image] =>[orig_patent_app_number] => 12751396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8944097 [patent_doc_number] => 08497276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Substituted indolo-piperidine compounds' [patent_app_type] => utility [patent_app_number] => 12/751360 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31034 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12751360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276310 [patent_doc_number] => 20100256210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'METHODS AND COMPOSITIONS FOR DELIVERING 5-HT3 ANTAGONISTS ACROSS THE ORAL MUCOSA' [patent_app_type] => utility [patent_app_number] => 12/750505 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12496 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256210.pdf [firstpage_image] =>[orig_patent_app_number] => 12750505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577086 [patent_doc_number] => 20100273825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'SOLID PHARMACEUTICAL COMPOSITION CONTAINING SOLIFENACIN AMORPHOUS FORM' [patent_app_type] => utility [patent_app_number] => 12/749209 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6427 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273825.pdf [firstpage_image] =>[orig_patent_app_number] => 12749209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733735 [patent_doc_number] => 20120016024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'Water-In-Oil Emulsion Composition' [patent_app_type] => utility [patent_app_number] => 13/256997 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9960 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016024.pdf [firstpage_image] =>[orig_patent_app_number] => 13256997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567647 [patent_doc_number] => 20100234342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'EZETIMIBE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/723808 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3013 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234342.pdf [firstpage_image] =>[orig_patent_app_number] => 12723808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645424 [patent_doc_number] => 20100227932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Patch' [patent_app_type] => utility [patent_app_number] => 12/721814 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5949 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227932.pdf [firstpage_image] =>[orig_patent_app_number] => 12721814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239829 [patent_doc_number] => 20120148564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'METHODS OF USING SNS-595 FOR TREATMENT OF CANCER SUBJECTS WITH REDUCED BRCA2 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/203718 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12945 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203718 [rel_patent_id] =>[rel_patent_doc_number] =>)